Research Paper Undergraduate 872 words

Risperidone's Cognitive Effects in Autistic Children

~5 min read

Abstract

This paper reviews a clinical trial investigating the cognitive effects of risperidone in children aged 5–17 with autism and severe irritable behavior. The study randomly assigned 38 participants (from 101 subjects) to receive risperidone (0.5–3.5 mg/day) or placebo for eight weeks, measuring sustained attention, verbal learning, hand-eye coordination, and spatial memory using repeated measures ANOVA. Results indicated improved performance on deletion and verbal learning tasks with risperidone, marginal gains on spatial memory tasks, and no significant changes in hand-eye coordination or timed math performance. The analysis concludes that risperidone at therapeutic doses shows no negative cognitive effects in this pediatric population.

📝 How to Write This Type of Paper Writing guide — click to expand

▼

What makes this paper effective

Clearly identifies the medication, population, and research question in the opening paragraph, establishing immediate context for readers unfamiliar with the clinical setting.
Distinguishes between study design elements (randomization, dosage ranges, treatment duration) and outcome measures, helping readers follow the experimental structure.
Provides specific results with quantitative detail (participant breakdown by task completion, improvement on specific cognitive tasks), grounding conclusions in actual data rather than generalizations.
Engages critically by proposing alternative study designs (including participants with schizophrenia) and reasoning about cognitive demands, demonstrating higher-order thinking beyond passive summarization.

Key academic technique demonstrated

The paper employs repeated measures ANOVA as its statistical framework, explaining both the conceptual purpose (comparing means across multiple time points) and the formula structure (F = MST/MSE). While the application of the formula to this specific dataset contains some interpretive challenges, the student demonstrates understanding of variance decomposition and the role of treatment versus error variance in inferential statistics.

Structure breakdown

The paper follows a standard empirical review structure: introduction of the clinical question and hypothesis, detailed account of methodology (participant selection, treatment assignment, dependent measures), explanation of the statistical test used, presentation of key results organized by cognitive domain, and a concluding interpretation of safety and efficacy. The student concludes by reflecting on study design choices and their reasoning, which extends beyond passive reporting into methodological critique.

Study Overview and Hypothesis

This study examines the cognitive effects of risperidone in children with autism and irritable behavior. Risperidone is an antipsychotic medication typically prescribed to treat schizophrenia and bipolar disorder, though its use has expanded to address severe behavioral disturbance in pediatric populations with autism spectrum disorder. The central hypothesis of this research focuses on whether risperidone affects the cognitive processes of individuals who take it, with particular attention to whether any cognitive impairment occurs as a side effect.

The study population consisted of children aged 5 through 17 years old who had been diagnosed with autism and irritable behavior. This age range captures a developmentally diverse group, from early school age through adolescence, allowing the researchers to examine whether cognitive effects vary across developmental stages. The choice of this population reflects clinical interest in using risperidone to manage severe behavioral symptoms while preserving or maintaining cognitive function in children with developmental disorders.

Methodology and Design

The researchers employed a randomized controlled trial design to isolate the effects of risperidone from placebo. Participants were randomly assigned to receive either risperidone at doses ranging from 0.5 to 3.5 mg per day or placebo for a treatment duration of eight weeks. This dosage range and timeline align with clinical practice guidelines for pediatric treatment of behavioral disturbance.

Of the 101 subjects enrolled in the clinical trial, 38 completed the cognitive testing component, while 63 were unable to perform the cognitive task. This attrition is notable and may reflect the practical challenges of administering complex cognitive batteries to children with developmental and behavioral difficulties. The dependent measures assessed four distinct cognitive domains: sustained attention, verbal learning, hand-eye coordination, and spatial memory. Assessments were conducted at three time points: before treatment began, during the eight-week treatment period, and after treatment concluded. This pre-post design with an intermediate assessment point allows detection of cognitive changes across the treatment timeline.

2 Locked Sections · 468 words remaining

Statistical Analysis and Results · 312 words

"ANOVA approach, participant completion rates, and cognitive task outcomes"

Clinical Implications and Interpretation · 156 words

"Safety profile and methodological considerations for future research"

You’re 35% through this paper. Sign up to read the remaining 2 sections.

130,000+ paper examples AI writing assistant Citation generator Cancel anytime

Key Concepts in This Paper

Risperidone Autism Spectrum Disorder Antipsychotic Medication Cognitive Performance Pediatric Psychopharmacology Clinical Trial Design Repeated Measures ANOVA Behavioral Disturbance Verbal Learning Treatment Safety